Phagenesis' Series B - II Round

Phagenesis raised a round of funding on May 22, 2013. Investors include Inventages Venture Capital.

Phagenesis has developed a clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient's ability to swallow is damaged. Dysphagia can lead to the inhalati…

Articles about Phagenesis' Series B - II Round: